The Patent Lawyer
NewsThe latest IP news – to join our panel of Patent news correspondents, please contact us
Anand and Anand successfully represents The Scent Stories in WIPO domain name dispute
New Delhi, September 1, 2026 - Anand and Anand has successfully represented The Scent Stories in proceedings before the WIPO Arbitration and Mediation Center, resulting in the dismissal of a complaint concerning the domain name www.thescentstories.com. In its...
Wi-Fi 7 Patent Landscape Report
Who is really leading the Wi-Fi 7 patent landscape? Wi-Fi 7 is rapidly moving toward widespread adoption, bringing a new generation of SEP licensing, portfolio, and litigation considerations. Insight IP’s latest research identifies 2,507 active, granted patent...
Anaqua study finds AI is redefining semiconductor innovation
The semiconductor industry is being transformed, and artificial intelligence (AI) is the driver. Anaqua, a leading provider of innovation and intellectual property (IP) management technology and services, today released key findings from its 2026 Semiconductor...
Drug Repurposing & Repositioning: Turning Scientific Opportunity into Commercial Reality
New Insight IP Boardroom Series Report | September 2026 Drug repurposing offers an attractive proposition: identifying new therapeutic uses for existing pharmaceutical compounds can reduce development timelines, leverage established safety data and lower some of the...
Australian generics turn preliminary discovery into patent validity tool
Generic drug companies are using preliminary discovery in Australia to investigate whether they have grounds to challenge the validity of pharmaceutical patents, in a potentially significant development for patent litigation strategy. The issue arose in proceedings...
Trade secrets and software: secrecy over public right to exclude
As software systems become central to business innovation, trade secret law is crucial for protecting them. The need to protect software and algorithms presents unique challenges for businesses that have long relied on patent protection. The nature of software often...
Delhi High Court holds “algorithms” and “computer program” not patentable
This article discusses an appeal filed by Kroll Information Assurance, LLC (Appellant), against the order of the Controller General of Patents, Designs, and Trademarks (CG). The appeal concerns the refusal of an Indian Patent Application No. 8100/DELNP/2007 for a...
Samsung’s $112M patent verdict: Maxell makes its mark in IP enforcement
In a significant setback for global tech giant Samsung, a Texas federal jury has handed down a USD 111.7 million verdict in favor of Maxell, ruling that Samsung infringed three patents covering user interface technology, multimedia processing, and smart networking....
Optis v. Apple: what the Federal Circuit’s decision means for functional claiming
The Federal Circuit's June 16, 2025, decision in Optis Cellular Technology, LLC v. Apple Inc., 2025 US App. LEXIS 14745 shines a renewed spotlight on a recurring challenge in patent law: functional claiming. Specifically, it reaffirms the court's willingness to apply...
Delhi High Court denies AbbVie’s anti-cMet ADC patent
This article discusses an appeal filed by AbbVie Biotherapeutics Inc. and AbbVie Inc. (Appellants) at the Delhi High Court against the refusal of their patent application (Application No. 201817047767) for an anti-cMet antibody-drug conjugate by the Assistant...
UPC and EPO diverge on inventive step: lessons from Amgen’s PCSK9 patent battle
In a landmark test of the new Unified Patent Court (UPC), the European patent landscape faces a striking divergence between the UPC and the European Patent Office (EPO) on the issue of inventive step. The dispute centers on Amgen's European patent EP 3 666 797, which...
Therapeutic efficacy is a must for a novel intermediate compound to overcome Section 3(d) objection
In an appeal case between Zeria Pharmaceutical Co. Ltd., v. The Controller of Patents (C.A.(COMM.IPD-PAT) 452/2022) before the Delhi High Court, wherein the appellant - a Japanese Corporation - filed an Indian Patent Application, numbered 3630/DLNP/2011 (the subject...
Should translation requirements apply equally in patent law?
A recent High Court judgment in India highlights a potential procedural fairness question in patent examination regarding English translation standards. While patent applicants face rigorous translation requirements under multiple Patent Rules, with severe...
UPC validates second medical use patent in Sanofi v. Amgen antibody therapeutics ruling, finds non-infringement
The Düsseldorf Local Division of the Unified Patent Court (UPC) has handed down a key decision in UPC CFI 505/2024, affirming the validity of a second medical use patent owned by Regeneron and licensed to Sanofi. The case involved alleged infringement by Amgen’s PCSK9...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.












